SuperworthBeta Bionics EPS BBNX
Diluted earnings per share by quarter and over the last twelve months, from 2024.
- Last 12 months, to Jun 30, 2026
- −$1.65
- Latest quarter, Q2 FY26
- −$0.53
- Fiscal year 2025
- −$1.95
Beta Bionics' earnings per share was −$1.65 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.53.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.95 | n/a |
| FY2024 | −$8.62 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.53 | n/a | −$1.65 | |
| Q1 FY26 | −$0.49 | n/a | −$1.51 | |
| Q4 FY25 | −$0.30 | n/a | −$1.95 | |
| Q3 FY25 | −$0.33 | n/a | −$4.37 | |
| Q2 FY25 | −$0.39 | n/a | −$5.50 | |
| Q1 FY25 | −$0.93 | n/a | −$7.48 | |
| Q4 FY24 | −$2.72 | n/a | −$8.62 | |
| Q3 FY24 | −$1.46 | n/a | n/a | |
| Q2 FY24 | −$2.37 | n/a | n/a | |
| Q1 FY24 | −$2.07 | n/a | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Beta Bionics' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| BBNXBeta Bionics | −$1.65 | |
| MOVMovado | $1.80 | +137% a year |
| IRMDIradimed | $1.79 | +10% a year |
| STAAStaar Surgical | $0.07 | |
| BVSBioventus | $0.77 | |
| CDRECadre | $0.81 | −14% a year |
| MDXGMimedx | $0.04 | −81% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| EYENational Vision | $0.61 | |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| Peer median | $0.94 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Beta Bionics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.